2018 AANS Annual Scientific Meeting-Legal Implications of Opioid Policy on the Clinician

Legal Implications of Opioid Policy on the Clinician

Video Transcription

Video Summary

In this video, Daniel Blaney-Cohen, an individual from the American Medical Association (AMA), addresses the legal implications of opioid policy and its impact on clinicians. He discusses various issues related to the opioid crisis, including the increase in new laws and regulations, legal cases against pharmaceutical manufacturers and distributors, criminal cases against healthcare professionals, and the role of prescription drug monitoring programs (PDMPs) in law enforcement. Blaney-Cohen emphasizes the need for meaningful and relevant education for physicians and the importance of collaborative efforts between medical societies. He also highlights the challenges faced by physicians in providing non-opioid alternatives to patients due to issues such as prior authorization and limited access to certain medications. He encourages physicians to share their experiences and barriers with organizations like the AMA to inform policy and legal advocacy.

Asset Caption

Daniel Blaney-Koen, JD, MFA

Keywords

opioid policy

legal implications

clinicians

opioid crisis

prescription drug monitoring programs

physician education